2011-11-14T10:13:30-05:00 2010-12-31 CBIZ MHM LLC 3101 N Central Ave Ste 300 Phoenix AZ 85012 990 2010-01-01 860707697 DONOR NETWORK OF ARIZONA DONO 6022222200 201 WEST COOLIDGE PHOENIX AZ 85013 KATHY MILLS 2011-11-11 6022646835 2010 2016-02-24 21:20:13Z TIM BROWN 201 W COOLIDGE PHOENIX AZ 85013 31755803 false X WWW.DNAZ.ORG X 1992 AZ TO MAKE THE MOST OF LIFE THROUGH THE GIFT OF ORGAN AND TISSUE DONATION AND TO CHALLANGE OURSELVES AND OTHERS EVERYDAY TO REALIZE ARIZONA'S POTENTIAL TO SAVE AND IMPROVE LIVES. 11 7 192 679 0 392123 324208 28122189 31125261 40240 189306 0 0 28554552 31638775 300 1500 0 0 11042477 12026876 0 0 0 14875327 16605119 25918104 28633495 2636448 3005280 15346267 20350996 3628920 5448230 11717347 14902766 X TO MAKE THE MOST OF LIFE THROUGH THE GIFT OF ORGAN AND TISSUE DONATION AND TO CHALLANGE OURSELVES AND OTHERS EVERYDAY TO REALIZE ARIZONA'S POTENTIAL TO SAVE AND IMPROVE LIVES. false false 15006761 18443601 ORGAN RECOVERY & PLACEMENT SERVICES - Donor Network of Arizona maximized the availability of high quality organs and tissues for transplant and research by providing services that are of expressed value to donors, recipients, donor families, donor hospitals, and transplant hospitals. DNA facilitated the donation and recovery of 424 Organs of which 389 were transplanted. These organs were recovered from 121 organ donors. 203 people received transplantable kidneys, 5 people received kidneys en bloc, 38 people received transplantable hearts, 91 people received transplantable livers, 1 person received a transplantable liver segment, ...continued on SCHedule O 3858366 7871787 Tissue & Ocular Recovery & Placement Services - The organization also facilitated the donation and recovery of various tissues for transplant purposes. 417 people donated bone for orthopedic purposes, 117 people donated heart valves, 236 saphenous veins were donated, 64 people donated pericardium, and 670 donated skin for burn victims, which was a record for skin recoveries by Donor Network of Arizona. In addition, 863 people donated corneas that resulted in 1205 corneal transplants, of which 202 of these were provided gratis for those who could not afford a transplant otherwise. The 1205 corneal transplants represented a 40% increase from the prior year. continued on SCHedule O 4227355 4809873 HLA LABORATORY SERVICES - The organization's Histocompatibility laboratory performed 16,541 tests, almost all of which were for the purpose of matching donors and recipients for kidney placement. 2814109 1500 25906591 true true false false false false false false false true false false false true true true false false false false false false false false false false false false true false false false false false false false false false false false false false false false false false false true 32 0 true 192 true false false false false false false false false false false X 11 7 false false false false false false false true true false false true true true true true true true true false AZ X KATHY MILLS 6022222200 201 W COOLIDGE PHOENIX AZ 85013 TIM BROWN 40.0 X X 314930 0 46708 ROBERT GROSS MD 0.3 X 21000 PHILIP KEEN MD 0.3 X 21000 MARTY ENRIQUEZ RN MS 0.2 X LAWRENCE J KOEP MD 0.2 X X JOHN PETERS 0.2 X SCOTT PETERSEN MD 0.2 X GLENNA SHAPIRO 0.2 X JUAN VILLA 0.2 X LAURIE WILSHUSEN 0.2 X JOSEPH ZABRAMSKI MD 0.2 X KATHY MILLS 32.0 X 144097 33653 ROXANNE SPERRY 40.0 X 164855 17189 JOHN DANILOVS 30.0 X 154253 0 PJ GERAGHTY 40.0 X 140580 32079 JENNIFER TREECE 40.0 X 120403 18525 SARA PACE JONES 40.0 X 124594 30748 ALAN TAYLOR 40.0 X 133221 25017 JACQUELYN WARN 40.0 X 114807 30497 1453740 0 234416 9 false true false LEWIS ROCA LEGAL FEES 149926 CREATIVE TESTING SOLUTIONS BLOOD TESTING 281564 2 296991 27217 324208 ORGAN PLACEMENT 900099 18443601 18443601 TISSUE PLACEMENT 900099 5234829 5234829 OCULAR PLACEMENT 900099 2636958 2636958 TISSUE TYPING 900099 4809873 4809873 31125261 142801 142801 0 0 149274 14259 112478 4550 36796 9709 46505 46505 0 0 0 0 31638775 31125261 189306 1500 1500 0 0 0 917685 559788 357897 0 7487490 6814195 673295 496836 429926 66910 2480586 2063652 416934 644279 572356 71923 0 160394 160394 77652 77652 0 0 18495 18495 265950 242817 23133 1548 1548 93800 83220 10580 218985 164239 54746 0 159297 159297 103066 102699 367 0 166516 163268 3248 20541 20541 0 640074 512059 128015 311300 311300 ORGAN/TISSUE/OCULAR RECOVERY 11126471 11126471 HLA LAB EXPENSES 1783023 1783023 PROFESSIONAL & PUBLIC ED 304665 304665 UTILITIES & R&M 608381 510141 98240 PRINTING & PUBLICATIONS 203695 203695 341266 108032 233234 28633495 25906591 2726904 0 25037 28288 3028568 5359591 57141 86814 4261085 5367636 300364 352873 491458 399037 8079742 3867677 4299138 4212065 2671181 4295499 187263 229162 25032 20031 15346267 20350996 2497767 4557497 750244 462069 380909 428664 3628920 5448230 X 11717347 14902766 11717347 14902766 15346267 20350996 X 3005280 180139 X false true true X false X 448349 299986 477730 392123 324208 1942396 20079552 23661206 26595679 28122189 31125261 129583887 20527901 23961192 27073409 28514312 31449469 131526283 131526283 141132 173064 54629 24650 142801 536276 141132 173064 54629 24650 142801 536276 1450 0 0 0 0 1450 20670483 24134256 27128038 28538962 31592270 132064009 0.99593 0.99619 0.00406 0.00380 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 733587 733587 3388626 1350127 2038499 539835 308022 231813 3417694 2209528 1208166 4212065 0 DEFERRED COMPENSATION 299079 DEFERRED RENT 129585 428664 31638775 28633495 3005280 180139 180139 3185419 31818914 180139 180139 31638775 31638775 28633495 28633495 28633495 FIN 48 Footnote Part X The organization evaluates its uncertain tax positions, if any, on a continual basis through review of its policies and procedures, review of its regular tax filings, and discussions with outside experts. X X X X X X false true false false false true false false false TIM BROWN 291192 0 16390 7348 28379 18329 361638 0 KATHY MILLS 135271 7886 940 15324 18329 177750 PJ GERAGHTY 131733 7057 1790 14503 17576 172659 ROXANNE SPERRY 155477 8413 965 10972 6217 182044 SARA PACE JONES 116123 6895 1576 13172 17576 155342 ALAN TAYLOR 124674 6975 1572 13801 11216 158238 JOHN DANILOVS 154253 0 0 0 0 154253 SCHEDULE J SUPPLEMENTAL INFORMATION 6A -- Bonus payments are made to all employees based on meeting organizational goals, however, bonuses for all employees are subject to the organization achieving 90% of budgeted net income for the year, unless otherwise voted upon by the board of directors. In 2007, DNA's Board of Directors authorized the establishment of a Deferred Compensation plan for nine of DNA's executives, which is based on years of service and projected retirement dates. In accordance with the Deferred Compensation plan, DNA is required to contribute 5 percent of each of the respective executive's base compensation for the respective year of employment. Contributed amounts for each employee is included in Schedule J, Part II, column C. PROGRAM DESCRIPTIONS Form 990, Part III 4A ORGAN RECOVERY & PLACEMENT SERVICES 23 people received transplantable pancreata, 1 person received a transplantable lung, 24 people received transplantable lungs en bloc, and 2 people received transplantable small intestines. The organization facilitated the importation of 180 transplantable organs from other geographical areas. 4B Tissue & Ocular Recovery & Placement Services These donors also donated sclera for transplantation purposes. 4D Donor Program Development - Hospital & Community Services - The hospital donor program development department is responsible for maximizing the total number of donors recovered for transplant in Arizona through the implementation of individualized donor programs based on comprehensive hospital assessment, analysis of the donor potential in Arizona, the implementation of ongoing quality process improvement and initiation and fostering of effective relationships within the professional community. Currently this department has 12 full-time coordinators and one manager who, in addition to the Director, provide education and services to over 120 hospitals throughout Arizona. In addition the department has one Data Coordinator who is responsible for medical record review and other quality monitors for the department and a professional education coordinator who is responsible for internal and external training. Donor Network of Arizona continues to utilize the best practices as defined by the U.S. Department of Health and Human Services' Breakthrough Collaboratives for organ donation and transplantation. This includes active participation in regional and national improvement efforts. These efforts continue to help us maximize conversion rates, donors and the number of organs transplanted per donor in Arizona. Donor Network of Arizona continues to work with the Arizona Hospital and Healthcare Association to spread the collaborative methodologies and improvements to all Arizona hospitals. Through this effort Donor Network of Arizona held champion training events at several Arizona as well as a monthly webinar education series. DNA continued implementation of our In-House Coordinator in two of our seven Level 1 Trauma Centers. The In-House Coordinator is based upon a Best Practice as identified through the Breakthrough Collaborative. While these coordinators are Organ Recovery Staff and respond to organ donation referrals, they also act as the Donor Program Coordinators for their assigned hospitals. The Hospital Donor Program Development Department conducts 400 - 600 professional education offerings each year and has provided designated requestor training to over 4,000 healthcare workers throughout the state. In addition, the hospital donor program development staff at Donor Network of Arizona coordinates special education events and projects and develops and maintains educational materials. 4D -- Donor Program Development - Community Development/Public Relations The focus of our community development / public relations department is to increase organ and tissue donor registration in Arizona by creating and expanding public outreach programs, distributing information and developing and expanding community partnerships. Some key public education highlights for 2010 included: - More than 240,000 people registered their decision to be a donor on the DonateLife AZ Registry. - DNA continued the Live It, Give It, Check It campaign with the Arizona Department of Transportation including promotional materials at all offices, newsletter articles, web promotion and more. - Volunteers contributed over 3600 hours of their time for outreach efforts and our internal projects. - There were 262 stories in Arizona that included the Donor Network of Arizona website and / or phone number. - Donor Network of Arizona also increased our presence in Social Media and ended the year with 4,161 likes on our Facebook page, 475 followers on Twitter and 1,844 views of our YouTube videos. - Meredith McCall rode on the Donate Life Float in the annual Rose Parade in Pasadena, CA as Arizona's representative. Meredith is a kidney pancreas recipient. Her brother was an organ donor several years ago. James McCall's image was also on the float as a Florograph. - More than 200 Public Speaking Engagements and Events. - Continued to use multiple portals to allow Arizonans to register including kiosks, forms, and mail. - University of Arizona won the Donate Life Campus Challenge in a competition during April to increase donation on college campuses in AZ. - Finalized the final year of a $1+million dollar grant from U.S. Department of Health and Human Services to reach out to the Hispanic community via swap meets in Tucson and Phoenix. GOVERNANCE, MANAGEMENT & DISCLOSURE PART VI SECTION B LINE 11: THE 990 IS PREPARED BY AN OUTSIDE ACCOUNTING FIRM AND, Upon completion, a draft is emailed to all members of the Board of Directors for their review and comment. After their review is complete, the firm is provided with any comments or changes and/or instructed to file the return. SECTION B LINE 12C: Internal Reporting All members of the DNA Board of Directors will be required to complete a conflict of interest disclosure statement upon affiliation with DNA or hiring and to update the statement at least annually. The Chief Executive Director shall prepare a report for the DNA Board of Directors' annual meeting listing all transactions between DNA and DNA Board of Directors. The report will include: - A description of the transaction and its date. - The amount of the transaction and its impact on DNA. - The name of the DNA Board of Director member involved and the name of the other entity, if any, and a description of the nature of the DNA Board of Director's interest in the transaction. If a conflict of interest cannot be avoided, the Board member who has a conflict of interest shall not vote on, participate in or attempt to influence any DNA decision affected by the conflict of interest, except to provide information as specifically requested by deciding committee or body. SECTION B LINES 15A&B: Procedure: Compensation Philosophy and Strategy The objectives of DNA's executive compensation program are to provide a competitive Executive total compensation program compared to other organizations of similar size and type, particularly healthcare organizations. DNA's philosophy is to: Strongly link pay with performance. Retain the talented senior management team and show that DNA values them. Ensure reasonable compensation as compared to peers. It is the committee's intent to use peer data from similar positions in similar organizations under similar circumstances. Position base salary competitively at least at the median labor market as compared to peers. Ensure that DNA's total compensation, including total cash compensation and employee and executive benefits, is positioned at competitive practice overall when DNA meets its key goals. - DNA provides an Executive compensation program that integrates all elements of compensation and benefits. - Base salary is market-based and reflects an individual's performance. Annually an individual's performance is evaluated relative to their position accountabilities and performance criteria as well as organizational accountabilities. - The Organizational Incentive Plan, DNA's annual incentive, rewards achievement on key organizational goals that represent success measures for organ procurement, eye and tissue organizations. Incentive goals strongly align with DNA's mission. The Plan rewards organization-wide performance to reinforce teamwork. A threshold of financial performance is necessary for the Plan to be affordable. Procedure: Compensation Committee Responsibilities and Duties The Compensation Committee will meet regularly as scheduled in conjunction with board meetings. The Compensation Committee will be responsible to contract an outside consultant to review and trend current market data and total executive compensation to ensure executives are reasonably compensated. This will be done at a minimum of two to three years or as needed. The Committee will oversee and supervise the consultant's work product. All compensation agreements and decisions made by the Committee will be made independently and with due diligence. All compensation agreements and decisions will be thoroughly documented in the Finance/Compensation Committee minutes or the Executive session board minutes as appropriate. Guidelines for documentation are as follows and will include: - Identification of attendees - Verification and statement that no member has a conflict of interest. - Documentation that those who have a conflict will be excused. - Identification of source and collection of compensation data Detailed documentation of the terms of the compensation being approved If compensation value differs from comparability data, the basis for determination will be stated. With each decision regarding executive compensation, the committee will be responsible to establish a "rebuttable presumption of reasonableness". In doing so, the Committee will: - Ensure participants are independent - Make decisions based on appropriate comparability data. - Ensure minutes reflect a written record of the committee's work. The Compensation Committee will report all decisions regarding executive compensation to the full Board. ALL REVIEWS WERE PERFORMED IN JANUARY 2011 OR ON DATE OF HIRE IF HIRED AFTER JANUARY 2011. SECTION C LINE 19: The organization's articles of incorporation, by-laws, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST. RECONCILIATION OF NET ASSETS PART XI LINE 5: UNREALIZED GAIN ON INVESTMENTS: $180,139